In 2025, the line between brand messaging and cultural commentary continued to blur. As the year ends, let’s look back at the ...

Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Amidst the Eggoz controversy a Raipur-based Cancer Surgeon shared a video on his Instagram handle explaining why people do ...

Neuroplasticity research shows that maternal brains are rewired for immense creativity and problem solving. How could GLP-1s ...

Starting Jan. 1, 2026, Pennsylvania will limit GLP‑1 weight‑loss drugs under Medicaid — threatening access for thousands of ...

Vibe check: Turning Point and their allies have described the debate in Manichean, light vs. dark, good vs. evil language. At ...

Pennsylvania has quietly moved to limit access next year to popular weight-loss drugs like Ozempic and Wegovy for residents ...

Bulgarians protest against a controversial budget and widespread corruption, with faith in mainstream media declining. Next, ...

Digital rights groups, policy analysts say compulsory, undeletable app undermines consent, may introduce nationwide security ...